Results 201 to 210 of about 699,460 (251)
Some of the next articles are maybe not open access.

Richard Pfeiffer's typhoid vaccine and Almroth Wright's claim to priority.

Vaccine, 2021
Following the 1892 cholera pandemic, Richard Pfeiffer, Director of the science section of Robert Koch's Institute for Hygiene in Berlin, began laboratory-based studies on the pathogenesis of the disease using an animal model.
J. Williamson, K. Gould, K. Brown
semanticscholar   +1 more source

Field evaluation of typhoid conjugate vaccine in a catch-up campaign among children aged 9 months to 15 years in Sindh, Pakistan.

Vaccine, 2022
BACKGROUND Typhoid conjugate vaccine (TCV) has recently been introduced in the expanded program for immunization (EPI) in Pakistan. Before its introduction in routine immunization, a onetime catchup campaign among children 9 months to 15 years old was ...
R. Thobani   +11 more
semanticscholar   +1 more source

Immune non-interference and safety study of Vi-DT typhoid conjugate vaccine with a measles, mumps and rubella containing vaccine in 9-15 months old Nepalese infants.

Vaccine, 2022
BACKGROUND Typhoid fever is a common disease in developing countries especially in the Indian subcontinent and Africa. The available typhoid conjugate vaccines (TCV) have been found to be highly immunogenic in infants and children less than 2 years of ...
T. Saluja   +22 more
semanticscholar   +1 more source

Typhoid vaccines

Sahel Medical Journal, 2001
Typhoid fever continues to be a major public health problem in developing countries with about 33 million cases per year. Protective efficacy of traditional acetone/phenol killed vaccines is similar to newer typhoid vaccines (Ty21A and Vi antigen vaccine) but side effects of these newer vaccines are considerably less.
A, Aggarwal, A K, Dutta
openaire   +2 more sources

Effectiveness of typhoid conjugate vaccine against culture-confirmed typhoid in a peri-urban setting in Karachi: A case-control study.

Vaccine, 2021
BACKGROUND Enteric fever, caused by Salmonella Typhi and S. Paratyphi, is a cause of high morbidity and mortality among children in South Asia. Rising antimicrobial resistance presents an additional challenge.
Rabab Batool   +7 more
semanticscholar   +1 more source

Accelerating Typhoid Conjugate Vaccine Introduction: What Can Be Learned From Prior New Vaccine Introduction Initiatives?

open access: yesClinical Infectious Diseases, 2019
The health consequences of typhoid, including increasing prevalence of drug-resistant strains, can stress healthcare systems. While vaccination is one of the most successful and cost-effective health interventions, vaccine introduction can take years and
Leslie P Jamka   +2 more
exaly   +3 more sources

Longevity of immune response after a single dose of typhoid conjugate vaccine against Salmonella Typhi among children in Hyderabad, Pakistan

International Journal of Infectious Diseases
Highlights • Salmonella Typhi can cause a potentially life-threatening infection, typhoid fever.• Typhoid conjugate vaccine (TCV) has been established as a safe, well-tolerated, and effective vaccine.• A high seroconversion was observed at 4-6 weeks ...
F. Qamar   +13 more
semanticscholar   +1 more source

Chitosan/alginate microparticles for the oral delivery of fowl typhoid vaccine: Innate and acquired immunity.

Vaccine, 2018
Oral fowl typhoid (FT) vaccine is necessary for improved flock vaccinations and economic growth. This study was undertaken to evaluate the immune responses of birds given oral fowl typhoid vaccine coated with chitosan/alginate microparticles and ...
E. Onuigbo   +4 more
semanticscholar   +1 more source

TYPHOID VACCINATION

Journal of the American Medical Association, 1916
In 1912 I immunized 898 patients of this hospital against typhoid fever and reported the procedure. 1 Inoculation of all patients was made a matter of rou tine, and the number of subjects immunized since the last report was written is 2,602. In view of the paucity of similar reports in American medical literature, it seems worth while to bring the ...
openaire   +1 more source

Home - About - Disclaimer - Privacy